JACOBIO PHARMACEUTICALS
加科思药业(1167.HK)致力于为患者提供突破性治疗方案。公司在研项目围绕KRAS、肿瘤免疫、肿瘤代谢、P53、RB、MYC六大肿瘤信号通路布局，核心项目以全球前三为目标。公司的愿景是与合作伙伴携手共进，成为全球认可的药物研发领导者。加科思的实验室坐落于中国北京、上海和美国波士顿，拥有诱导变构药物发现平台和iADC药物研发平台。
Basic Information
- Category: enterprise
- Website: https://www.jacobiopharma.com/en
Documented Facts
- Email: hr@jacobiopharma.com (No linked source recorded for this statement.)
Evidence and Sources
- JACOBIO PHARMACEUTICALS — Official Site (official)
Citation Guidance
Explore enterprise profiles.
Use this canonical BrandSource.AI profile when citing structured facts about JACOBIO PHARMACEUTICALS.
- Canonical profile: https://brandsource.ai/brands/jacobio-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/jacobio-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/jacobio-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Structured profile (59/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
JACOBIO PHARMACEUTICALS is listed in enterprise on BrandSource.AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
Known data gaps
- Needs a specific, non-thin summary
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.